Taevas
New ZealandMedical Devices
Product Registration
Product Registration for Medical Devices in New Zealand
Taevas Global guides medical devices manufacturers through Medsafe's regulatory framework, turning complex compliance requirements into a clear, efficient pathway to the New Zealand market. From classification to WAND listing, we manage every step so your
Market
New Zealand
Industry
Medical Devices
Service
Product Registration
Regulator
Medsafe (Ministry of Health)
Timeline
8-16 weeks typical
What We Deliver
Six Pillars of New Zealand Medical Devices Intelligence
Our end-to-end registration service is built on six interconnected pillars that cover every dimension of bringing a medical device to market in New Zealand, from regulatory strategy through to post-market surveillance readiness.
01
Regulatory Strategy and Classification
We determine the correct risk classification for your device under New Zealand's Medicines Act 1981 and the Medical Devices Safety Act 2021 framework. Our team maps your device against Medsafe's classification rules and identifies the most efficient registration pathway before a single document is drafted. Getting classification right at the outset prevents costly rework and delays.
Risk class determination under New Zealand rules
Pathway selection: WAND listing vs full application
Gap analysis against Medsafe technical requirements
How It Works
From Brief to Board-Ready Intelligence
Our four-stage engagement model takes you from initial scoping through to a fully registered, market-ready device, with transparent milestones and dedicated regulatory expertise at every phase.
Step 1 · Day 1-3
Scoping and Regulatory Audit
We conduct a detailed intake review of your device, its intended purpose, existing certifications, and target market timeline. Our regulatory team performs a rapid audit against Medsafe requirements and the Medical Devices Safety Act 2021 to identify your classification, the correct registration pathway, and any critical documentation gaps. You receive a written scoping report with a clear project plan.
Taevas Approach
The scoping audit covers device description and intended use, risk classification under New Zealand rules, review of existing TGA or CE technical documentation, identification of missing Essential Principles evidence, and a realistic timeline and cost estimate for full registration. This stage is the foundation that prevents surprises later in the process.
Market Snapshot
New Zealand Medical Devices Market at a Glance
NZ$0B+
Estimated Annual Market Value
0%
Projected Annual Growth Rate
0+
Active Medical Device Suppliers
0+
Devices Listed on WAND Database
Strong Import Dependency Creates Entry Opportunity
New Zealand imports the vast majority of its medical devices, with domestic manufacturing limited primarily to niche and specialist products. This structural reliance on overseas suppliers means international manufacturers with the right registration credentials can access a receptive market. Public hospital procurement through Health New Zealand and private sector purchasing both represent viable channels for registered devices.
Regulatory Reform Under the Medical Devices Safety Act 2021
New Zealand is transitioning to a strengthened regulatory framework under the Medical Devices Safety Act 2021, which introduces mandatory pre-market approval requirements for higher-risk devices, replacing the previous voluntary notification system. Manufacturers entering now must plan for compliance with both current Medsafe requirements and the incoming obligations under the new Act. Early engagement with the new framework provides a competitive advantage over manufacturers who delay.
Health New Zealand Procurement Drives Demand
The consolidation of New Zealand's district health boards into Health New Zealand (Te Whatu Ora) has centralised procurement decisions, creating larger, more predictable tender opportunities for registered medical device suppliers. Medsafe WAND listing is a prerequisite for participation in public tenders, making registration a commercial as well as regulatory necessity. Suppliers with established registrations are well-positioned as Health New Zealand standardises its device procurement processes.
Digital Health and Connected Devices Are Growing Segments
Demand for digital health technologies, remote patient monitoring devices, and software as a medical device (SaMD) is growing across New Zealand's healthcare system, accelerated by telehealth adoption following the COVID-19 pandemic. Medsafe is actively developing guidance on SaMD classification and registration, creating both opportunity and regulatory complexity for manufacturers in this space. Companies that engage early with Medsafe's evolving SaMD framework can establish first-mover positions in these high-growth segments.
What's Included
Everything in Your Registration Package
Every Taevas Global Product Registration engagement for New Zealand Medical Devices delivers eight concrete outputs that take your device from application to market-ready status.
Regulatory Strategy Report
A written report confirming your device's risk classification, the applicable Medsafe registration pathway, and a prioritised action plan with timelines and resource requirements.
Complete Technical File
A compiled and reviewed technical dossier including device description, risk management evidence, clinical evaluation, and conformity assessment documentation aligned to Medsafe's Essential Principles.
Essential Principles Compliance Checklist
A completed and signed Essential Principles for Safety and Performance checklist demonstrating how your device meets each applicable requirement under New Zealand regulations.
WAND Listing Application Package
The fully prepared WAND database submission, including all mandatory data fields, supporting document uploads, and sponsor declarations required by Medsafe for listing approval.
New Zealand Labelling and IFU Review
A compliance review of your product labelling and instructions for use against Medsafe's English-language and content requirements for the New Zealand market, with recommended amendments.
Local Sponsor Onboarding Documentation
Sponsor identification support, a template sponsor agreement covering all statutory obligations under the Medical Devices Safety Act 2021, and a sponsor briefing pack on ongoing responsibilities.
Post-Market Surveillance Plan
A tailored post-market surveillance plan covering adverse event reporting to Medsafe, field safety corrective action procedures, and periodic safety update reporting requirements for your device class.
Compliance Calendar and Renewal Schedule
A 24-month forward-looking compliance calendar covering WAND listing renewal dates, mandatory reporting deadlines, and regulatory change milestones relevant to your device under New Zealand law.
Who This Is For
Built for These Situations
First-Time Market Entry
International Manufacturer Entering New Zealand
Your device is registered in the EU, US, or Australia, and you want to extend your commercial footprint to New Zealand without building an internal regulatory team for a single market. Medsafe's requirements differ in important ways from TGA and CE frameworks, and navigating the WAND system for the first time adds risk and delay without specialist support. Taevas Global provides the local regulatory expertise and project management to get your device listed efficiently.
Outcome
WAND listing achieved within target timeline, with full documentation package and sponsor arrangements in place for immediate commercial supply.
Next Steps
After Product Registration, Most Clients Move To
FAQ
Common Questions
Get Started
Ready to Map Your New Zealand Opportunity?
Speak with a Taevas Global regulatory specialist today to get a clear picture of your registration pathway, timeline, and investment for the New Zealand medical devices market. We turn Medsafe complexity into a structured, manageable process.
Free initial regulatory scoping call with a New Zealand specialist
Clear classification and pathway assessment within 48 hours
End-to-end WAND listing management with no internal regulatory headcount required
Ongoing post-market compliance support after successful registration